References

Molecular epidemiology of the main druggable genetic alterations in non-small cell lung cancer.

10.3390/ijms22020612 · 2021 · External reference

NSCLC: current evidence on its pathogenesis. integrated treatment, and future perspectives.

10.3390/jcm14031025 · 2025 · External reference

The direct and indirect costs of cancer among the lower-income group: estimates from a pilot and feasibility study.

10.31557/apjcp.2023.24.2.489 · 2023 · External reference

The effect of financial toxicity on the association between perceived social support and negative emotions in post-surgical lung cancer patients: a cross-sectional study from high-middle income region in China.

10.1002/cam4.71256 · 2025 · External reference

Financial toxicity, family resilience and symptom burden in liver cancer patients: a cross-sectional study.

10.3389/fpsyg.2025.1747893 · 2026 · External reference

Risk factors for financial toxicity in patients with pancreatic cancer.

10.1002/cam4.70799 · 2025 · External reference

ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer.

10.1016/j.esmoop.2024.102992 · 2024 · External reference

Comprehensive score for financial toxicity and health-related quality of life in patients with cancer and survivors: a systematic review and meta-analysis.

10.1016/j.jval.2022.07.017 · 2023 · External reference

Effects of clinical and socioeconomic factors on Medicare and patient costs for colorectal cancer in Australia: a retrospective multivariate regression analysis.

10.1136/bmjopen-2023-081483 · 2024 · External reference

Effect of socioeconomic status on financial toxicity: the chain mediating roles of social support and self-efficacy.

10.1002/cam4.71083 · 2025 · External reference

Longitudinal trends of financial toxicity in patients with lung cancer: a prospective cohort study.

10.1200/op.20.00721 · 2021 · External reference

Machine learning prediction of financial toxicity in patients with resected lung cancer.

10.1097/xcs.0000000000001373 · 2025 · External reference

Development and validation of a simplified financial toxicity screening tool for use in clinical practice.

10.1200/op-24-00598 · 2025 · External reference

Development and validation of nursing-oriented risk prediction models for anxiety and depression in hospitalized patients with chronic kidney disease: a retrospective cross-sectional study in Southwest China.

10.3389/fpsyt.2025.1683467 · 2026 · External reference

Navigating financial toxicity in patients with cancer: a multidisciplinary management approach.

10.3322/caac.21730 · 2022 · External reference

Longitudinal studies on financial toxicity in cancer patients: a scoping review.

10.3389/fpubh.2026.1798871 · 2026 · External reference

Predictors of financial toxicity trajectories in patients with pancreatic cancer: a latent class growth analysis.

10.1002/cam4.70875 · 2025 · External reference

TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods.

10.1136/bmj-2023-078378 · 2024 · External reference

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

10.7326/0003-4819-147-8-200710160-00010-w1 · 2007 · External reference

Relationships between financial toxicity and symptom burden among cancer patients: a longitudinal study.

10.1016/j.lanwpc.2024.101367 · 2025 · External reference

The impact of fear of cancer recurrence on anxiety and depression in women with cancer: the chain mediating roles of financial toxicity and psychological distress - A multicenter investigative study.

10.1016/j.apjon.2025.100699 · 2025 · External reference

The relationship between resilience, financial toxicity, and quality of life in patients with primary liver cancer: a cross-sectional study.

10.1186/s12876-025-04458-x · 2025 · External reference

Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC).

10.1002/da.10113 · 2003 · External reference

PsychoPy2: experiments in behavior made easy.

10.3758/s13428-018-01193-y · 2019 · External reference

Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors.

10.1002/pon.1481 · 2009 · External reference

Psychometric Validation of a new module of MD Anderson Symptom Inventory (MDASI) for Patients with Upper Gastrointestinal Cancers: MDASI-UGI-Surg.

10.1245/s10434-025-18414-2 · 2026 · External reference

The general self-efficacy scale: multicultural validation studies.

10.3200/jrlp.139.5.439-457 · 2005 · External reference

Financial toxicity of patients with lung cancer in China: results from a national survey study.

10.1002/cam4.5244 · 2023 · External reference

The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment.

10.3322/caac.21443 · 2018 · External reference

Financial toxicity in patients with resected lung cancer.

10.1097/sla.0000000000005926 · 2023 · External reference

Financial toxicity in atherosclerotic cardiovascular disease in the United States: current state and future directions.

10.1161/jaha.120.017793 · 2020 · External reference

Financial toxicity in cancer care: origins, impact, and solutions.

10.1093/tbm/ibab091 · 2021 · External reference

Barriers to cancer treatment for people experiencing socioeconomic disadvantage in high-income countries: a scoping review.

10.1186/s12913-024-11129-2 · 2024 · External reference

Economic burden of lung cancer: a retrospective cohort study in South Korea, 2002-2015.

10.1371/journal.pone.0212878 · 2019 · External reference

The impact of financial toxicity on psychological well-being. coping self-efficacy, and cost-coping behaviors in young adults with cancer.

10.1089/jayao.2018.0143 · 2019 · External reference

Fear of recurrence in long-term breast cancer survivors-still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the cancer survivorship–a multi-regional population-based study.

10.1002/pon.3452 · 2014 · External reference

Developing a conceptual framework for socioeconomic impact research in european cancer patients: a ‘Best-Fit’. framework synthesis.

10.1007/s40271-023-00632-z · 2023 · External reference

Potential profile analysis of financial toxicity and its related factors among lung cancer patients.

10.1186/s12885-025-14076-1 · 2025 · External reference

Financial burden of men with localized prostate cancer: a process paper.

10.3389/fpsyg.2023.1176843 · 2023 · External reference

Maintenance therapy in metastatic solid tumors: innovative strategy or simple second-line treatment?

10.1097/coc.0000000000000574 · 2019 · External reference

Disparities in inpatient treatment and expenditures among lung cancer patients under tiered social health insurance: a population-based study in China.

10.1186/s12939-025-02533-z · 2025 · External reference

Cancer-related financial toxicity among Latinas with breast cancer in a rural area of the United States: a qualitative study.

10.1186/s12905-025-03692-5 · 2025 · External reference

The role of social support in buffering the financial toxicity of breast cancer: a qualitative study of patient experiences.

10.3390/cancers17101712 · 2025 · External reference

Development of a nomogram for predicting financial toxicity risk among lung cancer patients: a cross-sectional study.

10.1177/10547738251328410 · 2025 · External reference

Engaging nurses in effective cost of care conversations to address cancer-related financial toxicity: results from an exploratory survey.

10.3390/curroncol32010033 · 2025 · External reference

Cancer care affordability and the healthcare team: expanding an assessment of clinical perceptions and attitudes in nursing.

10.1188/25.onf.259-264 · 2025 · External reference